BPA Call 36C24122A0144-36C24122N0739
Award Date 8/1/22
Potential Completion Date 7/31/23
Potential Value $55K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Providence, RI 02908, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Luminex Corp has been awarded a Blanket Purchase Agreement (BPA) call valued at $92,743.36 for luminex reagents under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract, executed on August 1, 2024, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order from Veterans Integrated Service Network 1 (VISN 1), the Department of Veterans Affairs' regional network serving veterans across multiple northeastern states....
- This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
- This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
- Luminex Corporation was awarded a $463,944.32 delivery order against the General Services Administration (GSA) Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The firm fixed price order is for the delivery of Luminex SAR2 test kits to support COVID-19 testing efforts and has a period of performance through November 11, 2021. No set-aside designation was used for this...
- This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...
- Luminex Corporation was awarded a $14,009.44 delivery order against the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 is to provide a Luminex ARIES M2 System Analyzer to support COVID-19 testing efforts. Performance will occur in New Orleans, LA. The contract has no set-aside...
- This federal contract award to Luminex Corp is for the provision of reagents for an analyzer. The $41,461.00 firm fixed-price delivery order was awarded on October 1, 2025 by the Veterans Integrated Service Network 5, a civilian agency, with a performance period ending on September 30, 2026. The contract was not set aside for any socioeconomic categories. Luminex Corp is a foreign-owned, for-profit manufacturer of advanced biological testing technologies, and has received numerous federal...
- Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...
- Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...
- Luminex Corporation was awarded a $55,415.62 firm fixed price delivery order against its Multiple Award Schedule contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The contract supports COVID-19 testing by providing a Luminex analyzer to Tuskegee, Alabama. Issued on June 29, 2020 with a completion date of September 30, 2020, the delivery order was funded through the National Interest Action Code for Coronavirus and aims to bolster...